Search

JM to offer new process to synthesise ultra-pure cannabidiol

News: Today we announced a development in our API and controlled substances portfolio by establishing a new synthetic method for ultra-pure cannabidiol.

Den Jones to Step Down as Group Finance Director

Den will step down as Group Finance Director over the summer this year, when we anticipate a successor will have been identified

Johnson Matthey gets the gold for commitment to chemical engineering

IChemE Gold Corporate Partner status reflects Johnson Matthey's commitment to the next generation of chemical engineers and our championing of the profession

Johnson Matthey at 200 - aligned for growth

News: JM announces changes to its organisation.

JM opens market at London Stock Exchange to celebrate 200 years of inspiring science

News: Employees from JM’s UK operations joined Robert MacLeod, Chief Executive, as he opened the market at the London Stock Exchange this morning.

Preliminary results for the year ended 31st March 2017

News: Robust performance in challenging markets; continued investment for future growth.

First quarter trading in line with expectations and guidance for the full year unchanged

News: JM will hold the company’s Annual General Meeting today at 11.00 am in London and has issued the following trading statement ahead of the meeting.

Producing large volumes of clean hydrogen

Johnson Matthey led Consortium to Develop Advanced Technology for Fuel Cell Electric Vehicles

INSPIRE is a three year EU supported programme to validate the next generation of automotive fuel cell stack technology

Johnson Matthey Acquires Catacel

Catacel, based in Ohio, USA, is an innovative supplier of novel technology centred on the use of metal foil coated catalysts and sorbents to a range of process industries

Building Public Trust Award for People Reporting in the FTSE 100

Johnson Matthey has won the PwC Building Public Trust Award for People Reporting in the FTSE 100

Q3 Interim Management Statement 2012/13

Johnson Matthey today provides its third quarter Interim Management Statement covering the period from 1st October 2012 to 29th January 2013

Pre-close trading update

Pre-close trading updates ahead of full year financial results for the year ended 31st March 2020

Appointment of Sector Chief Executive, Health

News: Johnson Matthey is pleased to announce the appointment of Jason Apter as Sector Chief Executive, Health. He will join Johnson Matthey on 5th March and be based in the US.

Groundbreaking ceremony for Johnson Matthey's new factory in Gliwice, Poland

News: We held a ceremony for our new factory in Gliwice, Poland, which is being built to manufacture modern autocatalysts.

JM staff use 3D printing to help NHS

News: A significant number of individuals and teams at JM globally have started making parts for personal protective equipment (PPE).

Celebrating Ethics Week

Johnson Matthey Fine Chemicals launches new online catalyst store

News: Our new online catalyst store gives easy access to research quantities of commercial grade ligands and catalysts.

Dr Xiaozhi Liu to join Johnson Matthey as a Non-Executive Director

Dr Xiaozhi Liu joins the board as a Non-Executive Director of the company with effect from 2nd April 2019.

JM celebrates 200 years of inspiring science and sustained innovation

News: Johnson Matthey, one of the longest-trading businesses in the FTSE 100 Index, celebrates its 200th birthday this year.